Kun Chen, M.D., Ph.D. obtained his medical and doctoral degrees from Tongji Medical College, Huazhong University of Science and Technology. He completed a joint Ph.D. program at Harvard School of Dental Medicine, where he studied the role of the Wnt inhibitor SFRP4 in cortical bone remodeling and periosteal skeletal stem cell (SSC) function. Following his Ph.D., Dr. Chen worked as an orthopedic surgeon at The First Affiliated Hospital of USTC for four years, gaining extensive clinical experience in age-related skeletal disorders such as osteoporosis and non-healing fractures. He is currently a postdoctoral scholar in Dr. Thomas Ambrosi’s laboratory at the University of California, Davis, focusing on SSC-based regenerative strategies. His research investigates the molecular mechanisms of SSC aging and bone degeneration using spatial transcriptomics, single-cell RNA sequencing, and integrative molecular approaches. Dr. Chen has authored more than 30 SCI papers in leading journals, including Nature, Cell Stem Cell, PNAS, and Advanced Science. His long-term goal is to translate fundamental discoveries into innovative stem cell-based therapies for age-associated skeletal diseases.
Kun Chen, M.D., Ph.D. obtained his medical and doctoral degrees from Tongji Medical College, Huazhong University of Science and Technology. He completed a joint Ph.D. program at Harvard School of Dental Medicine, where he studied the role of the Wnt inhibitor SFRP4 in cortical bone remodeling and periosteal skeletal stem cell (SSC) function. Following his Ph.D., Dr. Chen worked as an orthopedic surgeon at The First Affiliated Hospital of USTC for four years, gaining extensive clinical experience in age-related skeletal disorders such as osteoporosis and non-healing fractures. He is currently a postdoctoral scholar in Dr. Thomas Ambrosi’s laboratory at the University of California, Davis, focusing on SSC-based regenerative strategies. His research investigates the molecular mechanisms of SSC aging and bone degeneration using spatial transcriptomics, single-cell RNA sequencing, and integrative molecular approaches. Dr. Chen has authored more than 30 SCI papers in leading journals, including Nature, Cell Stem Cell, PNAS, and Advanced Science. His long-term goal is to translate fundamental discoveries into innovative stem cell-based therapies for age-associated skeletal diseases.